Lebwohl MG - Search Results

1

Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).

Lebwohl MG, Leonardi CL, Mehta NN, Gottlieb AB, Mendelsohn AM, Parno J, Rozzo SJ, Menter A. Lebwohl MG, et al. J Am Acad Dermatol. 2020 Feb;82(2):519-522. doi: 10.1016/j.jaad.2019.09.042. Epub 2019 Sep 26. J Am Acad Dermatol. 2020. PMID: 31563641 Free article. No abstract available.

2

Peristomal pyoderma gangrenosum.

Keltz M, Lebwohl M, Bishop S. Keltz M, et al. J Am Acad Dermatol. 1992 Aug;27(2 Pt 2):360-4. doi: 10.1016/0190-9622(92)70200-y. J Am Acad Dermatol. 1992. PMID: 1387659 Review.

3

A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.

Olsen EA, Cram DL, Ellis CN, Hickman JG, Jacobson C, Jenkins EE, Lasser AE, Lebwohl M, Leibsohn E, Medansky RS, et al. Olsen EA, et al. J Am Acad Dermatol. 1991 Mar;24(3):443-7. doi: 10.1016/0190-9622(91)70069-e. J Am Acad Dermatol. 1991. PMID: 2061442 Clinical Trial.

4

Association of Pityrosporum orbiculare (Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS).

Groisser D, Bottone EJ, Lebwohl M. Groisser D, et al. J Am Acad Dermatol. 1989 May;20(5 Pt 1):770-3. doi: 10.1016/s0190-9622(89)70088-8. J Am Acad Dermatol. 1989. PMID: 2523907

5

Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy.

Lebwohl M, Martinez J, Weber P, DeLuca R. Lebwohl M, et al. J Am Acad Dermatol. 1995 Mar;32(3):469-71. doi: 10.1016/0190-9622(95)90071-3. J Am Acad Dermatol. 1995. PMID: 7868718

6

Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis.

Fryer EJ, Lebwohl M. Fryer EJ, et al. J Am Acad Dermatol. 1994 Apr;30(4):651-3. doi: 10.1016/s0190-9622(09)80116-3. J Am Acad Dermatol. 1994. PMID: 8157795 No abstract available.

7

Cutaneous reactions to vitamin K1 injections.

Lemlich G, Green M, Phelps R, Lebwohl M, Don P, Gordon M. Lemlich G, et al. J Am Acad Dermatol. 1993 Feb;28(2 Pt 2):345-7. doi: 10.1016/0190-9622(93)70051-t. J Am Acad Dermatol. 1993. PMID: 8436655

8

Infectious complications of erythrodermic psoriasis.

Green MS, Prystowsky JH, Cohen SR, Cohen JI, Lebwohl MG. Green MS, et al. Among authors: lebwohl mg. J Am Acad Dermatol. 1996 May;34(5 Pt 2):911-4. doi: 10.1016/s0190-9622(96)90078-x. J Am Acad Dermatol. 1996. PMID: 8621827

9

Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.

Menter MA, See JA, Amend WJ, Ellis CN, Krueger GG, Lebwohl M, Morison WL, Prystowsky JH, Roenigk HH Jr, Shupack JL, Silverman AK, Weinstein GD, Yocum DE, Zanolli MD. Menter MA, et al. J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):315-21. doi: 10.1016/s0190-9622(96)80148-4. J Am Acad Dermatol. 1996. PMID: 8642106 No abstract available.

10

A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.

Lebwohl M, Siskin SB, Epinette W, Breneman D, Funicella T, Kalb R, Moore J. Lebwohl M, et al. J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):268-9. doi: 10.1016/s0190-9622(96)90349-7. J Am Acad Dermatol. 1996. PMID: 8708035 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

690 results

Search Page